The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Diagnosis of hepatocellular carcinoma
Open accessAbstract
Hepatocellular carcinoma (HCC) is responsible for a large proportion of cancer deaths worldwide. HCC is frequently diagnosed after the development of clinical deterioration at which time survival is measured in months. Long-term survival requires detection of small tumors, often present in asymptomatic individuals, which may be more amenable to invasive therapeutic options. Surveillance of high-risk individuals for HCC is commonly performed using the serum marker alpha-fetoprotein (AFP) often in combination with ultrasonography. Various other serologic markers are currently being tested to help improve surveillance accuracy. Diagnosis of HCC often requires more sophisticated imaging modalities such as CT scan and MRI, which have multiphasic contrast enhancement capabilities. Serum AFP used alone can be helpful if levels are markedly elevated, which occurs in fewer than half of cases at time of diagnosis. Confirmation by liver biopsy can be performed under circumstances when the diagnosis of HCC remains unclear.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Bruix, J., Sherman, M., Llovet, J. M., Beaugrand, M., Lencioni, R., Burroughs, A. K., Christensen, E., Pagliaro, L., Colombo, M., & Rodés, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00130-1 · Cited by 4,089
Landis, S. H., Murray, T., Bolden, S., & Wingo, P. A. (1999) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.49.1.8 · Cited by 3,068
Rising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
Bravo, A. A., Sheth, S. G., & Chopra, S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102153440706 · Cited by 2,041
Estimates of the worldwide incidence of 25 major cancers in 1990
Parkin, Pisani, P., & Ferlay, J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990315)80:6<827::aid-ijc6>3.0.co;2-p · Cited by 2,037
Chang, M.-H., Chen, C.-J., Lai, M.-S., Hsu, H.-M., Wu, T.-C., Kong, M.-S., Liang, D.-C., Shau, W.-Y., & Chen, D.-S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706263362602 · Cited by 1,883 · cited 2×
“Prevention of hepatitis B with universal vaccination in children has been proven to significantly reduce the incidence of HCC [24].”
BackgroundHepatitis B virus.The major etiology of hepatocellular carcinoma
Beasley, R. P. (1988) · Cancer · doi:10.1002/1097-0142(19880515)61:10<1942::aid-cncr2820611003>3.0.co;2-j · Cited by 1,280
A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients
(1998) · Hepatology · doi:10.1002/hep.510280322 · Cited by 1,238
Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma
Yang, H.-I., Lu, S.-N., Liaw, Y.-F., You, S.-L., Sun, C.-A., Wang, L.-Y., Hsiao, C. K., Chen, P.-J., Chen, D.-S., & Chen, C.-J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013215 · Cited by 1,222
Global Epidemiology of Hepatocellular Carcinoma
McGlynn, K. A., Petrick, J. L., & London, W. T. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.01.001 · Cited by 908
Bolondi, L., Sofia, S., Siringo, S., Gaiani, S., Casali, A., Zironi, G., Piscaglia, F., Gramantieri, L., Zanetti, M., & Sherman, M. (2001) · Gut · doi:10.1136/gut.48.2.251 · Cited by 643
Des-γ-Carboxy (Abnormal) Prothrombin as a Serum Marker of Primary Hepatocellular Carcinoma
Liebman, H. A., Furie, B. C., Tong, M. J., Blanchard, R. A., Lo, K.-J., Lee, S.-D., Coleman, M. S., & Furie, B. (1984) · New England Journal of Medicine · doi:10.1056/nejm198405313102204 · Cited by 617
Hepatocellular carcinoma: Diagnosis and treatment
Befeler, A. S., & di Bisceglie, A. M. (2002) · Gastroenterology · doi:10.1053/gast.2002.33411 · Cited by 602
Self-citation(1997) · Hepatology · doi:10.1002/hep.510260701 · Cited by 569
Liver Transplantation for Hepatocellular Carcinoma
Bismuth, H., Majno, P., & Adam, R. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007120 · Cited by 561
Donato, F., Boffetta, P., & Puoti, M. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980130)75:3<347::aid-ijc4>3.0.co;2-2 · Cited by 543
Schafer, D. F., & Sorrell, M. F. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09148-x · Cited by 453
Gupta, S., Bent, S., & Kohlwes, J. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-1-200307010-00012 · Cited by 420
Marrero, J. A., Su, G. L., Wei, W., Emick, D., Conjeevaram, H. S., Fontana, R. J., & Lok, A. S. (2003) · Hepatology · doi:10.1053/jhep.2003.50195 · Cited by 387
Johnson, P. J. (2001) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70158-6 · Cited by 359
Hepatitis C Virus Genotypes and Risk of Hepatocellular Carcinoma in Cirrhosis: A Prospective Study
Bruno, S., Silini, E., Crosignani, A., Borzio, F., Leandro, G., Bono, F., Asti, M., Rossi, S., Larghi, A., Cerino, A., et al. (1997) · Hepatology · doi:10.1002/hep.510250344 · Cited by 358
Sherman, M., Peltekian, K. M., & Lee, C. (1995) · Hepatology · doi:10.1002/hep.1840220210 · Cited by 357
Krinsky, G. A., Lee, V. S., Theise, N. D., Weinreb, J. C., Rofsky, N. M., Diflo, T., & Teperman, L. W. (2001) · Radiology · doi:10.1148/radiology.219.2.r01ma40445 · Cited by 332
McMahon, B. J., Bulkow, L., Harpster, A., Snowball, M., Lanier, A., Sacco, F., Dunaway, E., & Williams, J. (2000) · Hepatology · doi:10.1053/jhep.2000.17914 · Cited by 327
Tangkijvanich, P., Anukulkarnkusol, N., Suwangool, P., Lertmaharit, S., Hanvivatvong, O., Kullavanijaya, P., & Poovorawan, Y. (2000) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200012000-00007 · Cited by 298
Taketa, K., Endo, Y., Sekiya, C., Tanikawa, K., Kōji, T., Taga, H., Satomura, S., Matsuura, S., Kawai, T., & Hirai, H. (1993) · PubMed · Cited by 297
Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis
Pateron, D., Ganne, N., Trinchet, J. C., Aurousseau, M. H., Mal, F., Meicler, C., Coderc, E., Reboullet, P., & Beaugrand, M. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80468-4 · Cited by 296
Takayasu, K., Moriyama, N., Muramatsu, Y., Makuuchi, M., Hasegawa, H., Okazaki, N., & Hirohashi, S. (1990) · American Journal of Roentgenology · doi:10.2214/ajr.155.1.1693808 · Cited by 266
ZAMAN, S. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91785-4 · Cited by 257
Bralet, M.-P., Régimbeau, J.-M., Pineau, P., Dubois, S., Loas, G., Degos, F., Valla, D., Belghiti, J., Degott, C., & Terris, B. (2000) · Hepatology · doi:10.1053/jhep.2000.9033 · Cited by 249
Aoyagi, Y., Suzuki, Y., Isemura, M., Nomoto, M., Sekine, C., Igarashi, K., & Ichida, F. (1988) · Cancer · doi:10.1002/1097-0142(19880215)61:4<769::aid-cncr2820610422>3.0.co;2-m · Cited by 162
Kato, Y., Nakata, K., Nagataki, S., Omagari, K., FURUKAWA, R., KUSUMOTO, Y., Mori, I., TAJIMA, H., Tanioka, H., & Yano, M. (1994) · Cancer · doi:10.1002/1097-0142(19941015)74:8<2234::aid-cncr2820740805>3.0.co;2-6 · Cited by 157
Tong, M. J., Blatt, L. M., & Kao, V. W. C. (2001) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2001.02470.x · Cited by 156
Des-γ-carboxy (abnormal) prothrombin and hepatocellular carcinoma: A critical review
Weitz, I. C., & Liebman, H. A. (1993) · Hepatology · doi:10.1002/hep.1840180434 · Cited by 152
Bisceglie, A. M. D., Carithers, R. L., & Gores, G. J. (1998) · Hepatology · doi:10.1002/hep.510280436 · Cited by 142
Screening for Hepatocellular Carcinoma in Patients With Advanced Cirrhosis
Chalasani, N., Horlander, J. C., Said, A. T., et al. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01448.x · Cited by 132
Delayed Enhancement of Fibrotic Areas in Hepatic Masses
Yoshikawa, J., Matsui, O., Kadoya, M., Gabata, T., Arai, K., & Takashima, T. (1992) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199203000-00006 · Cited by 117
Epidemiology and Clinical Presentation of Hepatocellular Carcinoma
Bisceglie, A. M. D. (2002) · Journal of Vascular and Interventional Radiology · doi:10.1016/s1051-0443(07)61783-7 · Cited by 113
Epidemiologic Approach for Cancer Screening
Prorok, P. C. (1992) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199205000-00005 · Cited by 92
Imaging in the Diagnosis, Staging, Treatment, and Surveillance of Hepatocellular Carcinoma
Szklaruk, J., Silverman, P. M., & Charnsangavej, C. (2003) · American Journal of Roentgenology · doi:10.2214/ajr.180.2.1800441 · Cited by 87
Hepatocellular carcinoma in primary biliary cirrhosis: Detection by α-fetoprotein estimation
Melia, W. M., Johnson, P. J., Neuberger, J., Zaman, S. N., Portmann, B. G., & Williams, R. L. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90540-7 · Cited by 83
McIntire, K. R., Vogel, C. L., Primack, A., Waldmann, T. A., & Kyalwazi, S. K. (1976) · Cancer · doi:10.1002/1097-0142(197602)37:2<677::aid-cncr2820370211>3.0.co;2-t · Cited by 83
Fracanzani, A. L., Taioli, E., Sampietro, M., Fatta, E., Bertelli, C., Fiorelli, G., & Fargion, S. R. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00160-x · Cited by 81
Screening for Cancer in Viral Hepatitis
Colombo, M. (2001) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70156-2 · Cited by 71
Caturelli, E., Bartolucci, F., Biasini, E., et al. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05477.x · Cited by 70
Mass screening for hepatocellular carcinoma: Experience in Hokkaido, Japan
Mima, S., Sekiya, C., KANAGAWA, H., Kohyama, H., Gotoh, K., Mizuo, H., Ijiri, M., Tanabe, T., MAEDA, N., & Okuda, K. (1994) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1994.tb01256.x · Cited by 58
Johnson, P. J., Poon, T. C. W., Hjelm, N. M., Ho, C. S., Ho, S. K. W., Welby, C., Stevenson, D., Patel, T., Parekh, R. B., & Townsend, R. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690828 · Cited by 57
Shimizu, K., Katoh, H., YAMASHITA, F., Tanaka, M., Tanikawa, K., Taketa, K., Satomura, S., & Matsuura, S. (1996) · Clinica Chimica Acta · doi:10.1016/0009-8981(96)06369-3 · Cited by 51
Screening for Hepatocellular Carcinoma
Koteish, A. A., & Thuluvath, P. J. (2002) · Journal of Vascular and Interventional Radiology · doi:10.1016/s1051-0443(07)61785-0 · Cited by 41
Stal, P. I. (2008) · Digestive Diseases · doi:10.1159/000171503 · Cited by 39
Choi, B. I., Kim, A., Lee, J. Y., Kim, K. W., Lee, K. H., Kim, T. K., & Han, J. K. (2002) · Journal of Ultrasound in Medicine · doi:10.7863/jum.2002.21.1.77 · Cited by 37
Hepatocellular carcinoma: predisposing conditions and precursor lesions
Bailey, M. A., & Brunt, E. M. (2003) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(03)00018-2 · Cited by 4
Cited by
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Benson, A. B., D’Angelica, M. I., Abbott, D. E., Anaya, D. A., Anders, R., Are, C., Bachini, M., Borad, M., Brown, D., Burgoyne, A., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0022 · Cited by 1,003
Thomas, M. B., Jaffe, D., Choti, M. M., Belghiti, J., Curley, S., Fong, Y., Gores, G., Kerlan, R., Merle, P., O'Neil, B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.7805 · Cited by 394
Chen, J., Yi, C., Okegbile, S. D., Cai, J., & Shen, X. (2024) · IEEE Communications Surveys & Tutorials · doi:10.1109/comst.2023.3308717 · Cited by 254
Analysis of cancer genomes reveals basic features of human aging and its role in cancer development
Podolskiy, D. I., Lobanov, A. V., Kryukov, G. V., & Gladyshev, V. N. (2016) · Nature Communications · doi:10.1038/ncomms12157 · Cited by 100
Metadata
- Authors
- Bialecki, E. S., & Di Bisceglie, A. M.
- Venue
- HPB
- Publisher
- Elsevier BV
- Published
- 2005-03
- Volume
- 7
- Issue
- 1
- Pages
- 26-34
- ISSN
- 1365-182X (ISSN-L)
- OpenAlex
- W1995000770
- Cited by
- 334
- References
- 52
- FWCI
- 0.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.